enVVeno Medical Corporation (NVNO)

NASDAQ: NVNO · Real-Time Price · USD

10.75

-0.49 (-4.36%)

At close: Aug 28, 2026, 4:00 PM EDT

10.70

-0.05 (-0.47%)

After-hours: Aug 28, 2026, 7:30 PM EDT

enVVeno Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2.84	3.07	1.75	3.62	4.56	54.73
Short-Term Investments	18.65	25.15	41.4	42.79	34.49	-
Cash & Short-Term Investments	21.49	28.21	43.15	46.41	39.04	54.73
Cash Growth	-38.86%	-34.62%	-7.02%	18.87%	-28.66%	486.29%
Prepaid Expenses	0.6	0.61	0.58	0.51	0.39	0.31
Total Current Assets	22.08	28.83	43.73	46.92	39.44	55.04
Property, Plant & Equipment	0.55	0.71	1.19	1.68	2.19	2.61
Other Long-Term Assets	0.03	0.03	0.03	0.03	0.03	0.05
Total Assets	22.66	29.56	44.95	48.64	41.66	57.7

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.54	0.36	1.01	0.43	0.65	0.56
Accrued Expenses	0.95	1.37	0.73	0.61	0.57	0.73
Current Portion of Leases	0.4	0.39	0.36	0.34	0.31	0.29
Total Current Liabilities	1.89	2.12	2.1	1.37	1.53	1.58
Long-Term Leases	0.1	0.31	0.7	1.06	1.4	1.72
Total Liabilities	1.99	2.43	2.8	2.44	2.93	3.3

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Additional Paid-In Capital	199.45	198.46	194.01	176.24	145.25	136.26
Retained Earnings	-178.78	-171.33	-151.86	-130.04	-106.52	-81.85
Total Common Equity	20.67	27.13	42.16	46.2	38.73	54.4
Shareholders' Equity	20.67	27.13	42.16	46.2	38.73	54.4
Total Liabilities & Equity	22.66	29.56	44.95	48.64	41.66	57.7

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.51	0.7	1.06	1.4	1.72	2.01
Net Cash (Debt)	20.98	27.51	42.09	45.01	37.33	52.72
Net Cash Growth	-38.76%	-34.63%	-6.49%	20.58%	-29.20%	523.64%
Net Cash Per Share	33.22	46.71	85.90	128.07	137.93	212.59
Filing Date Shares Outstanding	0.68	0.66	0.5	0.38	0.27	0.27
Total Common Shares Outstanding	0.67	0.66	0.5	0.38	0.27	0.27
Working Capital	20.2	26.7	41.64	45.55	37.91	53.46
Book Value Per Share	30.71	41.36	84.15	121.42	143.11	201.07
Tangible Book Value	20.67	27.13	42.16	46.2	38.73	54.4
Tangible Book Value Per Share	30.71	41.36	84.15	121.42	143.11	201.07
Machinery	-	1.44	1.44	1.4	1.37	0.81
Leasehold Improvements	-	-	-	-	-	0.19

SEC Filings: 10-K · 10-Q